These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21944383)

  • 1. Combined VEGF gene transfer and erythropoietin in ovine reperfused myocardial infarction.
    Olea FD; De Lorenzi A; Cortés C; Cuniberti L; Fazzi L; Flamenco Mdel P; Locatelli P; Cabeza Meckert P; Bercovich A; Laguens R; Crottogini A
    Int J Cardiol; 2013 May; 165(2):291-8. PubMed ID: 21944383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vascular endothelial growth factor gene transfer on infarct size, left ventricular function and myocardial perfusion in sheep after 2 months of coronary artery occlusion.
    Vera Janavel GL; De Lorenzi A; Cortés C; Olea FD; Cabeza Meckert P; Bercovich A; Criscuolo M; Laguens R; Crottogini A
    J Gene Med; 2012 Apr; 14(4):279-87. PubMed ID: 21954009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose erythropoietin has no long-term protective effects in sheep with reperfused myocardial infarction.
    Olea FD; Vera Janavel G; De Lorenzi A; Cuniberti L; Yannarelli G; Cabeza Meckert P; Cearras M; Laguens R; Crottogini A
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):736-41. PubMed ID: 16810073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome improvement of cellular cardiomyoplasty using triple therapy: mesenchymal stem cell+erythropoietin+vascular endothelial growth factor.
    Tavakoli F; Ostad SN; Khori V; Alizadeh AM; Sadeghpour A; Darbandi Azar A; Haghjoo M; Zare A; Nayebpour M
    Eur J Pharmacol; 2013 Aug; 714(1-3):456-63. PubMed ID: 23850947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with erythropoietin and granulocyte colony-stimulating factor enhances neovascularization and improves cardiac function after myocardial infarction.
    Xue J; Du G; Shi J; Li Y; Yasutake M; Liu L; Li J; Kong Y; Wang S; Yun F; Li W
    Chin Med J (Engl); 2014; 127(9):1677-83. PubMed ID: 24791874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial.
    Prunier F; Bière L; Gilard M; Boschat J; Mouquet F; Bauchart JJ; Charbonnier B; Genée O; Guérin P; Warin-Fresse K; Durand E; Lafont A; Christiaens L; Abi-Khalil W; Delépine S; Benard T; Furber A
    Am Heart J; 2012 Feb; 163(2):200-7.e1. PubMed ID: 22305837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction. VEGF gene therapy for myocardial infarction.
    Bull DA; Bailey SH; Rentz JJ; Zebrack JS; Lee M; Litwin SE; Kim SW
    J Control Release; 2003 Dec; 93(2):175-81. PubMed ID: 14636723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study.
    Ferrario M; Arbustini E; Massa M; Rosti V; Marziliano N; Raineri C; Campanelli R; Bertoletti A; De Ferrari GM; Klersy C; Angoli L; Bramucci E; Marinoni B; Ferlini M; Moretti E; Raisaro A; Repetto A; Schwartz PJ; Tavazzi L
    Int J Cardiol; 2011 Feb; 147(1):124-31. PubMed ID: 19906454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction.
    Guerrero M; Athota K; Moy J; Mehta LS; Laguens R; Crottogini A; Borrelli M; Corry P; Schoenherr D; Gentry R; Boura J; Grines CL; Raff GL; Shanley CJ; O'Neill WW
    J Interv Cardiol; 2008 Jun; 21(3):242-51. PubMed ID: 18422517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
    Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells overexpressing vascular endothelial growth factor in ovine myocardial infarction.
    Locatelli P; Olea FD; Hnatiuk A; De Lorenzi A; Cerdá M; Giménez CS; Sepúlveda D; Laguens R; Crottogini A
    Gene Ther; 2015 Jun; 22(6):449-57. PubMed ID: 25789461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
    van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep.
    Vera Janavel G; Crottogini A; Cabeza Meckert P; Cuniberti L; Mele A; Papouchado M; Fernández N; Bercovich A; Criscuolo M; Melo C; Laguens R
    Gene Ther; 2006 Aug; 13(15):1133-42. PubMed ID: 16572192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early erythropoietin therapy attenuates remodeling and preserves function of left ventricle in porcine myocardial infarction.
    Chua S; Leu S; Lin YC; Sheu JJ; Sun CK; Chung SY; Chai HT; Lee FY; Kao YH; Wu CJ; Chang LT; Ko SF; Yip HK
    J Investig Med; 2011 Mar; 59(3):574-86. PubMed ID: 21200333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of erythropoietin combined with granulocyte-colony stimulating factor in the treatment of acute myocardial infarction in rats].
    Fu ZH; Dong W; Gai LY; Wang F; Ding R; Chen YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):17-22. PubMed ID: 21269949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
    Cheng Y; Hu R; Lv L; Ling L; Jiang S
    J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
    Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat.
    Hale SL; Sesti C; Kloner RA
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):211-5. PubMed ID: 16044033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin enhances the angiogenic potency of autologous bone marrow stromal cells in a rat model of myocardial infarction.
    Zhang D; Zhang F; Zhang Y; Gao X; Li C; Ma W; Cao K
    Cardiology; 2007; 108(4):228-36. PubMed ID: 17106196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.